W
Waldo H. Belloso
Researcher at Hospital Italiano de Buenos Aires
Publications - 62
Citations - 4155
Waldo H. Belloso is an academic researcher from Hospital Italiano de Buenos Aires. The author has contributed to research in topics: Population & Clinical trial. The author has an hindex of 20, co-authored 59 publications receiving 3533 citations. Previous affiliations of Waldo H. Belloso include University of Buenos Aires.
Papers
More filters
Journal ArticleDOI
Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Lewis H. Kuller,Russell P. Tracy,Waldo H. Belloso,Stéphane De Wit,Fraser Drummond,H. Clifford Lane,Bruno Ledergerber,Jens D Lundgren,Jacqueline Neuhaus,Daniel E. Nixon,Nicholas I. Paton,James D. Neaton +11 more
TL;DR: IL-6 and D-dimer were strongly associated with an increased risk of all-cause mortality and Therapies that reduce the inflammatory response to HIV and decrease IL- 6 and D -dimer levels may warrant investigation.
Journal ArticleDOI
A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.
Ventura A Simonovich,Leandro Burgos Pratx,Paula Scibona,Maria Valeria Beruto,Marcelo Vallone,Carolina Vázquez,N. Savoy,Diego Giunta,Lucia Perez,Marisa Sanchez,Andrea V. Gamarnik,Diego Sebastian Ojeda,Diego Mario Santoro,Pablo J. Camino,Sebastian Antelo,Karina Rainero,Gabriela Vidiella,Erica A. Miyazaki,Wanda Cornistein,Omar A. Trabadelo,Fernando M. Ross,Mariano Spotti,Gabriel Funtowicz,Walter E. Scordo,Marcelo H. Losso,Inés Ferniot,Pablo E. Pardo,Eulalia Rodriguez,Pablo Rucci,Julieta Pasquali,Nora Fuentes,Mariano Esperatti,Gerardo A. Speroni,Esteban C. Nannini,Alejandra Matteaccio,Hernán G. Michelangelo,Dean Follmann,H. Clifford Lane,Waldo H. Belloso +38 more
TL;DR: No significant differences were observed in clinical status or overall mortality between patients treated with convalescent plasma and those who received placebo, and serious adverse events were similar in the two groups.
Journal ArticleDOI
Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
Daniel A. Duprez,Jacqueline Neuhaus,Lewis H. Kuller,Russell P. Tracy,Waldo H. Belloso,Stéphane De Wit,Fraser Drummond,H. Clifford Lane,Bruno Ledergerber,Jens D Lundgren,Daniel E. Nixon,Nicholas I. Paton,Ronald J. Prineas +12 more
TL;DR: In HIV-infected individuals, IL-6, hsCRP and D-dimer are associated with an increased risk of CVD independent of other CVD risk factors.
Journal ArticleDOI
Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial.
Andrew N. Phillips,Andrew Carr,Jacquie Neuhaus,Fehmida Visnegarwala,Ronald J. Prineas,William J. Burman,Ian Williams,Fraser Drummond,Daniel Duprez,Waldo H. Belloso,Frank D. Goebel,Birgit Grund,Angelos Hatzakis,J Vera,Jens D Lundgren +14 more
TL;DR: There was no clear evidence to suggest that ART interruption per se or a higher HIV viral load were associated with an increased CVD risk in the DC group, and Lipid changes were less favourable among DC compared with VS patients, which could offer a partial explanation.
Journal ArticleDOI
Changes in inflammatory and coagulation biomarkers: A randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection
Jason V. Baker,Jason V. Baker,Jacqueline Neuhaus,Daniel Duprez,Lewis H. Kuller,Russell P. Tracy,Waldo H. Belloso,Stéphane De Wit,Fraser Drummond,H. Clifford Lane,Bruno Ledergerber,Jens D Lundgren,Daniel E. Nixon,Nicholas I. Paton,James D. Neaton +14 more
TL;DR: In this randomized comparison of immediate versus delayed ART initiation, D-dimer, but not interleukin-6 and high sensitivity C-reactive protein, declined significantly after starting ART.